Email this article Efficacy and safety treatment of prolonged elapse pain syndroms
- Authors: Ignatov Y.D.1, Zaytsev A.A.1, Karpov О.I.1
-
Affiliations:
- The I. P. Pavlov State Medical University
- Issue: Vol 2, No 4 (2002)
- Pages: 50-55
- Section: Clinical medicine
- URL: https://ogarev-online.ru/MAJ/article/view/348898
- ID: 348898
Cite item
Open Access
Access granted
Subscription Access
Abstract
Centrally acting analgesic Tramadol and sustained-release Tramadol (Tramal long) is demonstrably good efficacy in moderate pain; it is free of some of the clinically significant adverse effects seen with opioid analgesics of similar efficacy, particularly respiratory depression. Tramadol causes minimal dependence and tolerance and has very low abuse potential; consequently it is not scheduled as a controlled drug. The attributes of Tramadol provide the clinician with a useful analgesic for short- and long-term use in the hospital and community settings.
About the authors
Y. D. Ignatov
The I. P. Pavlov State Medical University
Author for correspondence.
Email: shabanov@mail.rcom.ru
академик РАМН
Russian Federation, St. PetersburgA. A. Zaytsev
The I. P. Pavlov State Medical University
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg
О. I. Karpov
The I. P. Pavlov State Medical University
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg
References
- Игнатов Ю. Д., Зайцев А. А., Михайлович В. А., Страшнов В. И..Адренергическая аналгезия. СПб.: АНТ-М, 1994.216 с.
- Колчин В. В., Зайцев А. А. Влияние микроинъекции морфина и трамадола в голубое пятно на ноцицептивные ответы нейронов спинного мозга и сдвиги артериального давления // Бюл. экспер. биол. 1991. № 2. С. 126-128.
- Михайлович В. А., Игнатов Ю. Д. Болевой синдром. Л.: Медицина, 1990. 336 с.
- Осипова Н. А. Порядок и сроки назначения наркотических анальгетиков: Методические указания М3 РФ №2001/129 от 19. 07. 2001. М., 2001. 24 с.
- Bamigbade Т. A., Langford R. М. The clinical use of tramadol hydrochloride // Pain Rev. 1998. Vol. 5. P. 155-182.
- Coilart L., Luthy C., Dayer P. Multimodal analgesic effect of tramadol // Clin. Pharmacol. Ther. 1993. Vol. 53. P. 223.
- Cossmann M., Wilsmann К. M. Wirkungen und Begleitwirkungen von Tramadol: Offene Phase-IV-Prufung mit 7198 Patienten // Therapiewoche. 1987. Vol. 37. P. 3475-3485.
- Desmeules J. A., Piguet V., Collart L., Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol // Br. J. Clin. Pharmacol. 1996. Vol. 41. P. 7-12.
- Grond S., Meuser T., Zech D. et al. Analgesic efficacy and safety of tramadol enantiomers in comparison with racemate: a randomised, double-blindstudy in gynaecological patients using intravenous patient-controlled analgesia // Pain. 1995. Vol. 62. P. 313-320.
- Hahn E. E. Testing and evaluation of opiate analgesics and antagonists // Meth. Find. Exp. Clin. Pharmacol. 1985. Vol. 7. P. 373-381.
- Kayser V., Besson J. M., Gull baud G. Effects of the analgesic agent tramadol in normal and arthritic rats: comparison with the effects of different opioids, including tolerance and cross-tolerance to morphine // Eur. J. Pharmacol. 1991. Vol. 195. P. 37-45.
- Mattia A., Vanderah T., Raffa R. B. et al. Characterization of the unusual antinociceptive profile of tramadol in mice // Drug Dev. Res. 1993. Vol. 28. P. 176-182.
- Nossol S., Sdrwarzbold M., Stadler T. Treatment of pain with sustained-release tramadol 100, 150, 200 mg: results of a post-marketing surveillance study // IJCP. 1998. Vol. 52. P. 115-121.
- Preston К L., Jasinski D. R., Tesla M. Abuse potential and pharmacological comparison of tramadol and morphine // Drug Alcohol Depend. 1991. Vol. 27. P. 7-17.
- Raffa R. E, Friderichs E., Reimann W. et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an «atypical» opioid analgesic // J. Pharmacol. Exp. Ther. 1992. Vol. 260. P. 275-285.
- Raffa R. F A novel approach to the pharmacology of analgesics // Am. J. Med. 1996. Vol. 101 (suppl 1A). P. 40S—46S.
Supplementary files
